Longduoduo Company Limited LDDD

Q4 FY2026 · ended Jun 30, 2026 · Revenue $631,036, -32.9% YoY · Filed Sep 30, 2026

Longduoduo Company Limited (LDDD) files with the SEC under industry code 8000, Services-Health Services. In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $631,036 and a net loss of $62,974. Free cash flow was $274,497. As of Jun 30, 2026 it held $1.6 million in cash and investments and $49,070 in total debt.

Revenue
$631,036
-32.9% vs year-ago quarter
Net income
$-62,974
-138.6% vs year-ago quarter
Operating cash flow
$274,772
+49.2% vs year-ago quarter
Free cash flow
$274,497
+77.9% vs year-ago quarter
EPS
$-0.00
-138.6% vs year-ago quarter
Dividend per share
None
Shares outstanding
30.02M
+0.0% vs year-ago quarter
Net cash
$1.54M
Q4 FY2026
Operating margin
-11.4%
Q4 FY2026

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
LDDD (OTC)
Fiscal year ends
June 30
Incorporated in
NV
Headquarters
Hohhot
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1892316

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q4 FY2026
Jun 30, 2026
Q3 FY2026
Mar 31, 2026
Q2 FY2026
Dec 31, 2025
Q1 FY2026
Sep 30, 2025
Q4 FY2025
Jun 30, 2025
Revenue
$631,036
$187,392
$345,265
$658,764
$940,376
Operating income
-$72,131
-$197,443
-$279,193
-$84,414
$131,000
Net income
-$62,974
-$166,208
-$258,495
-$90,954
$163,145
Diluted EPS
-$0.00
-$0.01
-$0.01
-$0.00
$0.01
Operating cash flow
$274,772
-$332,309
$268,612
-$374,184
$184,215
Free cash flow
$274,497
-$332,584
$268,472
-$404,132
$154,294
Total assets
$2.1M
$1.7M
$2.1M
$1.9M
$2.1M
Total liabilities
$1.3M
$957,123
$1.1M
$700,555
$830,464
Stockholders' equity
$703,691
$736,924
$880,361
$1.1M
$1.2M
Cash and investments
$1.6M
$1.2M
$1.5M
$1.2M
$1.6M
Total debt
$49,070
$67,714
$66,236
$64,496
$18,570

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-K Annual report Sep 30, 2026 Jun 30, 2026
8-K Current report
Officer or director change
Sep 16, 2026 Sep 14, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
10-Q Quarterly report Feb 9, 2026 Dec 31, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
10-K Annual report Sep 26, 2025 Jun 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.